Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Francesca Miccichè"'
Autor:
Alessandro Salvi, Italia Bongarzone, Francesca Miccichè, Bruna Arici, Sergio Barlati, Giuseppina De Petro
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 11, Iss 2, Pp 207-219 (2009)
In human hepatocellular carcinoma (HCC), the high expression of urokinase-type plasminogen activator (uPA) is an unfavorable prognostic factor and a therapeutic target. To identify the downstream effects of uPA silencing by RNA interference, we studi
Externí odkaz:
https://doaj.org/article/1f1f6c9115734979bcf64c3ea82ca092
Autor:
Francesca Miccichè, Luca Da Riva, Marina Fabbi, Silvana Pilotti, Piera Mondellini, Silvano Ferrini, Silvana Canevari, Marco A Pierotti, Italia Bongarzone
Publikováno v:
PLoS ONE, Vol 6, Iss 2, p e17141 (2011)
Activated leukocyte cell adhesion molecule (ALCAM, CD166) is expressed in various tissues, cancers, and cancer-initiating cells. Alterations in expression of ALCAM have been reported in several human tumors, and cell adhesion functions have been prop
Externí odkaz:
https://doaj.org/article/f3169bd251464e939c4cd1602af325e4
Autor:
Elena Vaghi, Debora Formisano, Alberto Cavazza, Francesca Miccichè, Massimiliano Paci, Italia Bongarzone, Alessia Ciarrocchi, Laura Canovi, Maida De Bortoli, Sally Maramotti, Giorgio Sgarbi
Publikováno v:
Lung Cancer. 76:332-338
Epidermal growth factor receptor (EGFR) is implicated in tumor development and is highly expressed in many human tumors. EGFR overexpression has been observed in both premalignant lesions and in malignant lung tumors, as well as in 40–80% of patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8458ed6dfc3c6f9f77398e26b48bd5ab
https://doi.org/10.1016/j.lungcan.2011.11.018
https://doi.org/10.1016/j.lungcan.2011.11.018
Autor:
Cristiana Carniti, Maida De Bortoli, Italia Bongarzone, Piera Mondellini, Francesca Miccichè, Laura Zanetti Domingues, Dario Caccia
Publikováno v:
Journal of proteome research. 10(9)
In principle, targeted therapies have optimal activity against a specific subset of tumors that depend upon the targeted molecule or pathway for growth, survival, or metastasis. Consequently, it is important in drug development and clinical practice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04c12b2a72ab3040054473182ced7422
https://pubmed.ncbi.nlm.nih.gov/21751813
https://pubmed.ncbi.nlm.nih.gov/21751813
Autor:
Francesca Miccichè, Italia Bongarzone, Patrizia Casalini, Dario Caccia, Piera Mondellini, Giuliana Cassinelli
Publikováno v:
Molecular Cancer, Vol 9, Iss 1, p 278 (2010)
Molecular Cancer
Molecular Cancer
Background TPC-1 is a papillary thyroid carcinoma (PTC)-derived cell line that spontaneously expresses the oncogene RET/PTC1. TPC-1 treated with the RET/PTC1 inhibitor RPI-1 displayed a cytostatic and reversible inhibition of cell proliferation and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c18f4429300764776e72f33025fbc994
http://www.molecular-cancer.com/content/9/1/278
http://www.molecular-cancer.com/content/9/1/278
Autor:
Maurizio Colecchia, Francesca Miccichè, Claudius Mueller, Silvia Veneroni, Italia Bongarzone, Virginia Espina, Mariaelena Pierobon, Mattia Cremona, Emanuel F. Petricoin, Cinzia Lanzi, Jianghong Deng, Lance A. Liotta, Giuseppe Procopio
Publikováno v:
Journal of Clinical Oncology. 30:434-434
434 Background: There are marked differences in responses to therapy among patients with clear cell renal cell carcinoma (ccRCC), which makes the outcome difficult to predict. This study is aimed to define a new classification system that would eluci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::10e445a930d95d909fb62dfe0317ba48
https://doi.org/10.1200/jco.2012.30.5_suppl.434
https://doi.org/10.1200/jco.2012.30.5_suppl.434
Autor:
Italia Bongarzone, Elena Vaghi, Elena Tamborini, Marco A. Pierotti, Francesca Miccichè, Fabio Bozzi, Silvana Pilotti, Veronica Huber, Luca Da Riva, Alessandro Gronchi, Eva Tarantino, Elena Fumagalli, Piera Mondellini
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 9, Iss 1, p 158 (2011)
Journal of Translational Medicine, Vol 9, Iss 1, p 158 (2011)
Background Gastrointestinal stromal tumors (GISTs) are the most frequent mesenchymal tumors to develop in the digestive tract. These tumors are highly resistant to conventional chemotherapy and only the introduction of imatinib mesylate has improved
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ed01078d3e65801aa5c96a5f441b5e5
http://europepmc.org/articles/PMC3192683
http://europepmc.org/articles/PMC3192683
Autor:
Luca Da Riva, Marina Fabbi, Italia Bongarzone, Silvana Pilotti, Piera Mondellini, Silvano Ferrini, Marco A. Pierotti, Silvana Canevari, Francesca Miccichè
Publikováno v:
PLoS ONE
PLoS ONE, Vol 6, Iss 2, p e17141 (2011)
PLoS ONE, Vol 6, Iss 2, p e17141 (2011)
Activated leukocyte cell adhesion molecule (ALCAM, CD166) is expressed in various tissues, cancers, and cancer-initiating cells. Alterations in expression of ALCAM have been reported in several human tumors, and cell adhesion functions have been prop
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc280be6228706eca85f2f0082d7df36
https://doi.org/10.1371/journal.pone.0017141
https://doi.org/10.1371/journal.pone.0017141
Autor:
Gaia C. Ghedini, Italia Bongarzone, Antonello Cabras, A. M. Gianni, Serenella M. Pupa, Lorenzo Castagnoli, Carmelo Carlo-Stella, M Di Nicola, Francesca Miccichè, Roberta Zappasodi
Publikováno v:
ResearcherID
e18513 Background: We reported that dendritic cell-based vaccination in relapsed indolent NHL patients achieved clinical benefits strongly associated with B and T cell responses. Hence, we exploited the antibody (Ab) repertoires of responders (R) and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9b5c3f8673216d28aab459ddd7c670e
https://doi.org/10.1200/jco.2010.28.15_suppl.e18513
https://doi.org/10.1200/jco.2010.28.15_suppl.e18513
Autor:
Francesca Miccichè, Alessandro Salvi, Italia Bongarzone, Sergio Barlati, Bruna Arici, Giuseppina De Petro
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 11, Iss 2, Pp 207-219 (2009)
In human hepatocellular carcinoma (HCC), the high expression of urokinase-type plasminogen activator (uPA) is an unfavorable prognostic factor and a therapeutic target. To identify the downstream effects of uPA silencing by RNA interference, we studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c91969d9f135560bb0116106ab28e12